This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Emerging Market ADRs: Winners and Losers

NEW YORK (TheStreet) -- During the past week, global markets were trading upward, mainly spurred by positive manufacturing data from around the world and easing concerns over the economic recovery. The Dow Jones and the S&P 500 gained 2.6% and 3%, respectively. Among emerging markets, India's Nifty increased the most, with gains of 3.4%, while Brazil's Bovespa was up 2.3%. The Shanghai Composite Index was down marginally by 0.3%.

China: Winners and Losers

Simcere Pharmaceutical Group (SCR) was the top gainer during the last week with an increase of 18.5%. Linktone (LTON) accumulated 16.2% during the week, after the Chinese media entertainment company reported a 43% revenue growth during the third quarter compared to the year-ago quarter. For the fourth quarter, the company expects to record revenues in the range of $20 million-$21 million compared to $19.8 million in the current quarter.

Silvercorp Metals (SVM) was up 15.8% during the week. China Shen Zhou Mining & Resources (SHZ) scaled up 14.5% last week. Recently, the company said that net revenues are estimated to increase by 164% in 2011 vis-à-vis 2010 levels. For 2010, net revenues are seen at $14.5 million, up from $4.2 million in 2009.

Meanwhile, Suntech Power Holdings (STP) jumped 13.1% after the company was upgraded by Auriga, which raised its price target to $11 from the earlier $9. Analysts at the research firm added that the stock has limited downside and company-specific positive developments should encourage investors to build long-term positions on the stock. Sina (SINA) was up 11.7%.

China Architectural Engineering (CAEI) topped the losers' list, plummeting 24.6%. A-Power Energy Generation Systems (APWR) lost 19.7% after the company lowered its 2010 guidance. The company said that it estimates revenue to come in at $310 million, lower than both its previous guidance of $500 million and Reuters estimates of $441 million. It added that revenues were subdued mainly due to lower-than-estimated wind turbine sales. Net income guidance was down to $50 million compared to analysts estimates of $72 million.

China Medical Technologies (CMED) tumbled 14.3%. The company announced recently that it has increased its size of the previously announced offering of convertible senior notes, pricing it at $125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The issue was closed yesterday.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,493.37 -69.93 -0.42%
S&P 500 1,925.15 -5.52 -0.29%
NASDAQ 4,352.6390 -17.1340 -0.39%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs